|
AP7935a-ev
|
Abcepta, Inc.
|
PKN beta [C-term] [RB1043], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
AP7935a
|
Abcepta, Inc.
|
PKN beta [C-term] [RB1043], Rabbit Polyclonal Antibody
|
Human
|
IHC-P, WB
|
|
|
CT372
|
U-CyTech Biosciences
|
U-CyTech anti-CD3/CD28 stimulus for human PBMC
|
Human
|
ELISPOT
|
|
|
ATGL0002-100ug
|
NKMax Bio (ATGen)
|
293T Cell Lysate
|
Human
|
WB
|
|
|
ATGL0002-500ug
|
NKMax Bio (ATGen)
|
293T Cell Lysate
|
Human
|
WB
|
|
|
ATGL0029-100ug
|
NKMax Bio (ATGen)
|
K562 Cell Lysate
|
Human
|
WB
|
|
|
ATGL0029-500ug
|
NKMax Bio (ATGen)
|
K562 Cell Lysate
|
Human
|
WB
|
|
|
ATGL0031-100ug
|
NKMax Bio (ATGen)
|
L-929 Cell Lysate
|
Mouse
|
WB
|
|
|
ATGL0031-500ug
|
NKMax Bio (ATGen)
|
L-929 Cell Lysate
|
Mouse
|
WB
|
|
|
HY-108507-1mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-10559-10mg
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10559-100mg
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10559-25mg
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10559-5mg
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10559-50mg
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10559-1mL
|
MedChemexpress LLC
|
Nelotanserin [CAS 839713-36-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P2185A-1mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-P2185A-10mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-P2185A-5mg
|
MedChemexpress LLC
|
NFF-3 (TFA)
|
|
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
